Welcome to the homepage of the Institute of Cardiovascular Regeneration. Main focus of our Institute is the research and development of potential therapeutics for the treatment of cardiovascular diseases. The Institute elucidates the basic mechanisms underlying cardiovascular disease and vessel growth with the aim to develop new cellular and pharmacological therapies for improving the treatment of cardiovascular disease. Ongoing research focuses on epigenetic mechanisms that control cardiovascular repair, specifically the function of histone modifying enzymes and non-coding RNAs. Our lab is an international and interdisciplinary team consisting of independent group leaders as well as Postdocs with a medical and basic science background, PhDs and MD students and research associates.
NEWS: Research
Clonal Hematopoiesis-Driver DNMT3A Mutations Alter Immune Cells in Heart Failure
Clonal hematopoiesis driven by mutations of DNMT3A …
Endothelial cells show transient mesenchymal phenotype after infarct
Endothelial cells show a remarkable plasticity after myocardial infarction ..
Safety and efficacy of first microRNA for CVD in humans confirmed
The microRNA therapy with the anti-miR-92a (MRG-110) showed a …
NEWS: Awards & Grants
EVBO best presentation prize for Anita Tamiato
Best talk at EVBO summer school Award on…
2 ERC Advanced Grants for the ICR
Two ERC Advanced Grants for Stefanie Dimmeler and Andreas Zeiher for…
Young-Investigator Award and Poster Prize for the ICR
ICR postdocs receive prizes and awards at the DGK Jahrestagung 2022…